1.	Phase I-II Chemotherapy with Galactitol for Advanced Brain, Lung, Breast, Gastrointestinal and Genitourinary Tumors Phase: Phase II, Phase I Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: MAYO-705642
2.	Phase I-II Chemotherapy with CTX, ADR, DAG, VP-16, PZD and TZT for Solid Tumors Phase: Phase II, Phase I Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: MAYO-750302
3.	CAP-I (CTX/ADR/CACP) vs DAG/ADR/CACP for Squamous Cell Lung Cancer with VCR or VBL for Failures (Summary last modified 06/97) Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: NCI-D77-020-265, MAYO-772251, NCCTG-772251
4.	Phase II Early Trial of Dianhydrogalactitol plus BCNU for Advanced Cancer Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCI-D78-020-108, MAYO-780301
5.	Phase II Chemotherapy with Galactitol for Carcinoma, Sarcoma and Leukemia in Children Phase: Phase II Type: Treatment Status: Closed Age: under 18 Sponsor: NCI Protocol IDs: POG-7604
6.	Phase II Chemotherapy with Dianhydrogalactitol for Primary and Secondary Brain Tumors Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: BTRC-3
7.	Phase II Chemotherapy with Galactitol for Treatment of Advanced Carcinoma Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-7520
8.	Phase II Chemotherapy with Single Agents Selected by Soft Agar Colony Sensitivity Studies for Advanced Renal Carcinoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAYO-805002, NCCTG-805002, NCI-W81-0587
9.	Phase II Single-Agent Chemotherapy in Patients with Advanced Ovarian Carcinoma Using Agents Selected by Soft Agar Colony Sensitivity Studies Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAYO-816101
10.	Phase II Single-Agent Chemotherapy with DAG for Grade IV Malignant Central Nervous System Tumors Phase: Phase II Type: Treatment Status: Closed Age: over 18 Sponsor: Protocol IDs: NCI-D79-035-116
11.	Phase II Chemotherapy with Dianhydrogalactitol for Advanced Carcinoma of the Lung and for Melanoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: CLB-0702
12.	Phase II Master Protocol for Advanced, Recurrent Gynecologic Malignancies: Dianhydrogalactitol Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: GOG-26E
13.	Phase II Dianhydrogalactitol as a Synchronizing Agent Prior to Chemotherapy with MTX/VCR in Patients with Refractory or Metastatic Cancer Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCI-D81-045-430
14.	Phase II Chemotherapy with DAG for Grade III/IV Astrocytoma Resistant to Radiotherapy and Nitrosoureas Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCI-D82-006-645, YALE-HIC-2467
15.	Phase II Chemotherapy with DAG/BCNU/PALA for Recurrent Primary Brain Tumors Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAYO-817202, NCI-W81-0563
16.	Phase II Pilot Study of Dianhydrogalactitol for Advanced Metastatic Malignancies Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: PCCC-PU-7744
17.	Phase II L-PAM/DAG plus Total Body Irradiation for Neuroblastoma, with 6OH-Dopamine/Ascorbic Acid Treated Autologous Bone Marrow for Reconstitution Phase: Phase II Type: Treatment Status: Closed Age: 45 and under Sponsor: NCI Protocol IDs: MSKCC-8178, NCI-T83-0869W, T83-0869
18.	Phase II Pilot Chemotherapy with CACP plus Radiotherapy plus VP-16/L-PAM/DAG plus Autologous Bone Marrow Therapy for Refractory Metastatic Rhabdomyosarcoma Phase: Phase II Type: Treatment Status: Closed Age: under 21 Sponsor: NCI Protocol IDs: MSKCC-8410, NCI-T84-0359D, T84-0359
19.	Phase II Pilot Study of DAG/CACP Chemotherapy for Advanced Squamous Cancer of the Uterine Cervix Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: EST-PC-879
20.	Phase II Chemotherapy with CTX, VP-16, Galactitol and Hormonal Therapy with Megestrol for Advanced Renal Adenocarcinoma Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: EST-1874, MAYO-706025
21.	Phase II Trials of 13 Additional Chemotherapeutic Agents, Alone or Combined for non-Small Cell Lung Cancer Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: EST-2575-II
22.	A Master Protocol for Phase II Chemotherapy for Advanced Pancreatic Carcinoma --- HMM, DAG, b-TGdR, ICRF-159 Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: GITSG-9376A
23.	Phase II Single-Agent Chemotherapy with VP-16 vs Dianhydrogalactitol for Disseminated Malignant Melanoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAYO-705612
24.	Phase II Chemotherapy with CTX, ADR, VP-16, VCR, cis-Platinum, PZD, TZT and DAG for Solid Tumors Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAYO-750305
25.	Phase II Chemotherapy with Galactitol Versus Combination of VP-16 and ADR for Unresectable Adenocarcinoma of the Lung Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: MAYO-752101